Eli Lilly and (LLY)
826.57
4.06 (0.49%)
At close: Mar 31, 2025, 3:59 PM
825.03
-0.19%
Pre-market: Apr 01, 2025, 04:01 AM EDT
Oncology Revenue
History
| Quarter | Value | Change | Growth |
|---|---|---|---|
| Sep 30, 2024 | 2.23B | 421.8M | +23.30% |
| Mar 31, 2024 | 1.81B | 62.9M | +3.60% |
| Sep 30, 2023 | 1.75B | 76.1M | +4.55% |
| Jun 30, 2023 | 1.67B | 315M | +23.23% |
| Mar 31, 2023 | 1.36B | 62.7M | +4.85% |
| Sep 30, 2022 | 1.29B | -75.4M | -5.51% |
| Jun 30, 2022 | 1.37B | 15.7M | +1.16% |
| Mar 31, 2022 | 1.35B | -53.1M | -3.78% |
| Sep 30, 2021 | 1.41B | -147.9M | -9.52% |
| Jun 30, 2021 | 1.55B | 181.8M | +13.25% |
| Mar 31, 2021 | 1.37B | 38.8M | +2.91% |
| Sep 30, 2020 | 1.33B | 64.8M | +5.11% |
| Jun 30, 2020 | 1.27B | 67.1M | +5.58% |
| Mar 31, 2020 | 1.2B | 54.1M | +4.72% |
| Sep 30, 2019 | 1.15B | -49.8M | -4.16% |
| Jun 30, 2019 | 1.2B | 184.5M | +18.22% |
| Mar 31, 2019 | 1.01B | n/a | n/a |
| Mar 31, 2016 | n/a | n/a | n/a |
| Dec 31, 2015 | n/a | n/a | n/a |
| Sep 30, 2015 | n/a | n/a | n/a |
| Jun 30, 2015 | n/a | n/a | n/a |
| Mar 31, 2015 | n/a | n/a | n/a |
| Dec 31, 2014 | n/a | n/a | n/a |
| Sep 30, 2014 | n/a | n/a | n/a |
| Jun 30, 2014 | n/a | n/a | n/a |
| Mar 31, 2014 | n/a | n/a | n/a |
| Dec 31, 2013 | n/a | n/a | n/a |
| Sep 30, 2013 | n/a | n/a | n/a |
| Jun 30, 2013 | n/a | n/a | n/a |
| Mar 31, 2013 | n/a | n/a | n/a |
| Dec 31, 2012 | n/a | n/a | n/a |
| Sep 30, 2012 | n/a | n/a | n/a |
| Jun 30, 2012 | n/a | n/a | n/a |
| Mar 31, 2012 | n/a | n/a | n/a |
| Jun 30, 2011 | 59.5M | -780.4M | -92.92% |
| Mar 31, 2011 | 839.9M | n/a | n/a |